AETHLON MEDICAL INC | 0,100 Euro | -0,003 -2,91 % | |
| WKN: A0CADS ISIN: US00808Y1091 Ticker-Symbol: EJU | Stuttgart | 25.05.12 | 08:09 Uhr |
Branche GesundheitswesenAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 15.05. | Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference | 9 | PR Newswire | |
| SAN DIEGO, May 15, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO James A. Joyce will present at today's Security Research Associates (SRA) 8th Annual Growth... Mehr lesen zu: Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference | ||||
| 08.05. | Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy | 30 | PR Newswire | |
| SAN DIEGO, May 8, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening... Mehr lesen zu: Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy | ||||
| 03.05. | Aethlon Medical Note: Fiscal Year Revenue Guidance | 7 | PR Newswire | |
| SAN DIEGO, May 3, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
On... Mehr lesen zu: Aethlon Medical Note: Fiscal Year Revenue Guidance | ||||
| 26.04. | Aethlon Medical Note: Human Cytomegalovirus (HCMV) Validation | 9 | PR Newswire | |
| SAN DIEGO, April 26, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)... Mehr lesen zu: Aethlon Medical Note: Human Cytomegalovirus (HCMV) Validation | ||||
| 25.04. | Aethlon Medical Note: Marc Robins Joins the Aethlon Team | 8 | PR Newswire | |
| SAN DIEGO, April 25, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)... Mehr lesen zu: Aethlon Medical Note: Marc Robins Joins the Aethlon Team | ||||
| 24.04. | Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® | 8 | PR Newswire | |
| SAN DIEGO, April 24, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
The... Mehr lesen zu: Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® | ||||
| 16.02. | AETHLON MEDICAL INC - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 07.02. | Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd Annual Dialysis Conference | 19 | PR Newswire | |
| SAN DIEGO, Feb. 7, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and... Mehr lesen zu: Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd Annual Dialysis Conference | ||||
| 01.02. | Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol | 33 | PR Newswire | |
| SAN DIEGO, Feb. 1, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening... Mehr lesen zu: Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol | ||||
| 23.01. | Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board | 28 | PR Newswire | |
| SAN DIEGO, Jan. 23, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer... Mehr lesen zu: Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board | ||||
| 12.01. | Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board | 9 | PR Newswire | |
| SAN DIEGO, Jan. 12, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and... Mehr lesen zu: Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board | ||||
| 09.01. | Aethlon Medical Discloses Availability of the Biotech Showcase' 2012 Presentation | 33 | PR Newswire | |
| SAN DIEGO, Jan. 9, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer,... Mehr lesen zu: Aethlon Medical Discloses Availability of the Biotech Showcase' 2012 Presentation | ||||
| 04.01. | Aethlon Medical Announces Biotech Showcase' 2012 Presentation | 39 | PR Newswire | |
| SAN DIEGO, Jan. 4, 2012 /PRNewswire/--Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced... Mehr lesen zu: Aethlon Medical Announces Biotech Showcase' 2012 Presentation | ||||
| 13.12. | Aethlon Medical Announces HIV-AIDS Research Discovery | 18 | PR Newswire | |
| SAN DIEGO, Dec. 13, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer... Mehr lesen zu: Aethlon Medical Announces HIV-AIDS Research Discovery | ||||
| 06.12. | Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes | 22 | PR Newswire | |
| SAN DIEGO, Dec. 6, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that... Mehr lesen zu: Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
